,,iv #aacth ,,congress #b;d ,session ,h4 ,,res4 #ebh ,,in ,,the ,,house ,,of ,,representatives ,march #bg1 #bjad ,mr4 ,bachus 7for himself1 ,mr4 ,rangel1 ,mr4 ,higgins1 ,mr4 ,honda1 ,mr4 ,johnson of ,georgia1 ,mrs4 ,capito1 ,ms4 ,norton1 ,mr4 ,rice of ,south ,carolina1 ,mr4 ,hastings of ,florida1 ,mr4 ,danny ,k4 ,davis of ,illinois1 and ,mr4 ,byrne7 submitted the following resolution2 which was referred to the ,committee on ,oversight and ,government ,reform ,,resolution ,expressing support for designation of ,march #bjad as ,national ,multiple ,myeloma ,awareness ,month4 ,whereas multiple myeloma 7or myeloma7 is a cancer of plasma cells in the bone marrow and is called 8multiple0 because it can occur at various sites in the body2 ,whereas multiple myeloma causes a variety of adverse health effects1 including a weakened immune system1 anemia1 kidney damage1 and bone deterioration2 ,whereas multiple myeloma is the second most common blood cancer worldwide2 ,whereas multiple myeloma currently affects more than #ajj1jjj people in the ,united ,states1 with about #bb1cej new cases diagnosed and #aj1gaj deaths from the disease in #bjac according to the ,national ,cancer ,institute's ,surveillance1 ,epidemiology1 and ,end ,results ,program2 ,whereas once predominately found among those #fe and over1 where it continues to be most frequently diagnosed1 multiple myeloma is increasingly being identified in younger age individuals including those in their #cjs1 #djs1 and #ejs2 ,whereas multiple myeloma is almost twice as likely to occur among ,african-,americans and is one of the leading causes of cancer deaths among ,african-,americans1 with scientific understanding of the disparity remaining unknown2 ,whereas the cause of multiple myeloma is not known1 with robust research being performed in the ,united ,states and internationally into potential genetic1 environmental1 and other risk factors2 ,whereas recent years have seen the development of new drugs and treatments that have improved life expectancies and significantly enhanced the quality of life for patients2 ,whereas additional new drugs and therapies are in the research phase1 with patient enrollment in clinical trials playing an important role in determining safe and effective treatments2 ,whereas understanding and treatment of multiple myeloma has been greatly furthered by the role of advocacy initiatives promoting awareness1 education1 research1 peer review1 and collaboration and such efforts are to be highly commended2 ,whereas greater awareness of multiple myeloma on the part of clinicians and the general public can lead to earlier detection and treatment1 improving health outcomes and bringing comfort to patients and their families2 and ,whereas ,march #bjad would be an appropriate month to designate as ,national ,multiple ,myeloma ,awareness ,month3 ,now1 therefore1 be it ,that the ,house of ,representatives supports the designation of 8,national ,multiple ,myeloma ,awareness ,month0 to increase public knowledge of this disease and advance the vision of finding a cure for multiple myeloma4